Antiperspirant Labeling Determined Appropriate In FDA Petition Denial
This article was originally published in The Rose Sheet
Executive Summary
Modified labeling is not necessary for OTC antiperspirants because they can readily incorporate the information required under the final monograph in the "Drug Facts" format, FDA says in a letter to the Cosmetic, Toiletry and Fragrance Association